Aromatase Inhibitors: Did you decide to go on them or not?
Nanaloves: I’m about to start arimidex and just feel that the contraindications , bone issues etc. are overwhelming. I’m 70 years old, dodged a bullet I feel with zero stage DCIS but the follow up is pretty much no different then if it was more aggressive. I’ve just done 33 treatments of radiation and now they advise arimidex as a preventative. I’m not sure with the beginnings of arthritis and lower back. sensitivity already that I should take it. Anyone not take it and not have a recurrence within the 5 years.
Interested in more discussions like this? Go to the Breast Cancer Support Group.
@kilkennyfarmwife,
As @auntieoakley mentioned, you may wish to contact Mayo Clinic’s Office of Patient Experience.
Mayo Clinic Office of Patient Experience
Phone: 844-544-0036 (toll free)
Email: opx@mayo.edu
Have you ever explored the webinar offerings of Mayo's Cancer Education Center? They've moved many of their classes about nutrition, exercise, stress, bone health, etc. online so that they are accessible whether you're at Mayo Clinic or back at home. Follow the Cancer Education blog and class listings here: https://connect.mayoclinic.org/blog/cancer-education-center/
@muradangie and @roch may have more tips of classes and services available to you as a Mayo Clinic breast patient. For example, did you see an oncology dietician/nutrition specialist? Did you know that this sevice exists?
Thanks. So in a sense the tests are measuring different things as well. Or different things at different stages.
For what it's worth, I would likely have done what you did because of the LVI.
I do think it's interesting that Oncotype's website gives examples of scores which purely clinical evaluation might have seen differently. The patient with a large, stage 4 tumor and lymph involvement and low risk according to the test at least. And a patient with a grade 0, clean lymph biopsy but a risk for recurrence of 50+% according to the test.
That certainly seems counter-intuitive and, for the grade 0 patient, might have yielded a more-attentive post-surgical follow-through since some doctors are considering grade 0 almost a pre-cancer.
For what it's worth, the science guy I talked to at Oncotype said that, from what they see, the grade 0 specimens being submitted to them 'are definitely cancer' and his inference was that the medical community might be underestimating their seriousness.
They told me that 30% of grade 3's have low Oncotype scores.
@kilkennyfarmwife I am sorry for your troubles. Have you tried a different manufacturer for your anastrazole? Or tried Femara instead? You could also try alternate days. The difference between a 9% risk and a 4.5% risk seems significant to me, but I understand if that is not how you feel.
I am so grateful for aromatase inhibitors, because they allow us to avoid chemo. But I was lucky in finding Femara easy to tolerate. I switched to brand name Femara from generic anastrazole. In general I do well with TEVA if I have to take a generic.
I believe that Zometa can cause dental problems mostly in cancer patients who take very high doses, and also after several years of use. I am not sure about teeth falling out because jaw necrosis is what we usually hear about. Biphosphonates are useful with aromatase inhibitor treatment because those drugs cause bone loss. I believe that Reclast is gentler than Zometa. My doc even said a partial dose could be used, with Benadryl and tylenol beforehand, hydration and a slower infusion. You could also consider Fosamax orally if you don't have GERD.
Your mother's story is disturbing but 30 years ago they were giving biphosphonate drugs even for early osteopenia and did not yet know that extended use after 5-10 (I am not sure) years would cause brittler bones, and atypical fractures. You don't say how long your mother was on a biphosphonate. Can you tell us?
I have declined many drugs, including blood thinners. However, I have a kid on insulin for type 1 diabetes and an anti-convulsant for seizures. I am grateful to researchers and drug companies for these because without them she would not be alive.
I am on Tymlos now after cancer treatment. Once you have fractures, these bone-growing drugs provide hope. Was your mother ever offered Forteo? I am so sorry for her pain.
Our Cancer Education Center is open Monday-Friday 8-5 pm. If you have questions about any of our classes our Center's number is 507-266-9288.
I agree with you! No one in this process even mentions nutrition. I highly recommend
drjohnmcdougall.com for great info on nutrition and cancer.
Would you post a link from the education center specifically on nutrition? The link you posted led me to the nutrition specialist service which did not appear to be free.
I would add one thing. A lot of women with breast cancer take both chemo and aromatase inhibitors. They are not substitutes for each other, though some oncologists only recommend the AIs for what they evaluate as low recurrence- rate risk cancers.
I've never heard that so have no opinion other than wonder if that is true today, after OnctotypeDX has been offering the DX test for several years now.
What your mother has endured is awful. I think that, were she being treated for osteoporosis today, for the first time, the outlook would be more promising.
Fosamax, the first bisphosphonate if I recall correctly was never designed to be given for multiple decades. In fact Merck has consistently declined to design a long-term study of its efficacy and safety. (My career included researching corporations for a Wall Street investment manager. My cynicism was hard-earned and I suspect that Merck prefers to maintain plausible deniabality as the long-term adverse effects lawsuits pile up. And that corporate counsel suggest they not ask 'inconvenient' questions but no one need share my dim view.]
Fosamax was intended to be marketed to women in their early-to-mid 70s at a time when the life expectancy would suggest they'd be on it for a decade at best on average. [Note that now it's being marketed to ever younger women and I wonder why the FDA is silent about that mission creep.]
We've outlived a lot of drugs' usefulness, ironically enough, and that is good news.
I think it's all a balancing act and some people will be, as you are, more proactive in trying to improve the variables under their control and, just maybe, need way fewer pharmaceuticals. And be less willing to take them without some serious pondering of the risk/reward balance. That's good news too ;-).